Heart Team risk assessment with angiography-derived fractional flow reserve determining the optimal revascularization strategy in patients with multivessel disease: Trial design and rationale for the DECISION QFR randomized trial.
Miyata K, Asano T, Saito A, Abe K, Tanigaki T, Hoshino M, Kobayashi T, Takaoka Y, Kanie T, Yamasaki M, Yoshino K, Wakabayashi N, Ouchi K, Kodama H, Shiina Y, Tamaki R, Nishihata Y, Masuda K, Suzuki T, Nonaka H, Emori H, Katagiri Y, Miyazaki Y, Sotomi Y, Yasunaga M, Kogame N, Kuramitsu S, Reiber JHC, Okamura T, Higuchi Y, Kakuta T, Misumi H, Komiyama N, Matsuo H, Tanabe K; DECISION QFR investigators.
Miyata K, et al. Among authors: nonaka h.
Clin Cardiol. 2022 Jun;45(6):605-613. doi: 10.1002/clc.23821. Epub 2022 Mar 31.
Clin Cardiol. 2022.
PMID: 35362109
Free PMC article.
Clinical Trial.